These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1123 related articles for article (PubMed ID: 15455608)
1. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A; Naderi AS Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [TBL] [Abstract][Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577 [TBL] [Abstract][Full Text] [Related]
4. Association of white blood cell count with left ventricular hypertrophy and ejection fraction in stable hemodialysis patients. Nasri H Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):31-6. PubMed ID: 17237888 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis. Baradaran A; Nasri H Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254 [TBL] [Abstract][Full Text] [Related]
7. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients. Nasri H; Kheiri S Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021 [TBL] [Abstract][Full Text] [Related]
8. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease. Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662 [TBL] [Abstract][Full Text] [Related]
9. [Hyperthyroidism, therapy with erythropoietin, malnutrition and systolic function in hemodialysis: echocardiography study]. Iannetti E; Carpinteri G; Vitale M; Squatrito R; Catalano D; Trovato GM Recenti Prog Med; 2000 Dec; 91(12):632-5. PubMed ID: 11194481 [TBL] [Abstract][Full Text] [Related]
10. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251 [TBL] [Abstract][Full Text] [Related]
11. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis. Bradran A; Nasri H J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964 [TBL] [Abstract][Full Text] [Related]
12. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia]. Stojimirović B; Petrović D; Obrenović R Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184 [TBL] [Abstract][Full Text] [Related]
13. [TrueFISP MR imaging to determine the influence of hemodialysis on the myocardial functional parameters in patients with terminal renal insufficiency]. Kramer U; Wolf S; Fenchel M; Kraft A; Tomaschko K; Stauder N; Risler T; Claussen CD; Miller S Rofo; 2004 Mar; 176(3):350-6. PubMed ID: 15026948 [TBL] [Abstract][Full Text] [Related]
14. Correlation of serum parathormone with hypertension in chronic renal failure patients treated with hemodialysis. Baradaran A; Nasri H Saudi J Kidney Dis Transpl; 2005; 16(3):288-92. PubMed ID: 17642794 [TBL] [Abstract][Full Text] [Related]
15. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
17. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. Petrović D; Obrenović R; Stojimirović B Clin Lab; 2008; 54(5-6):145-52. PubMed ID: 18780659 [TBL] [Abstract][Full Text] [Related]
18. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Takeda K; Nakamoto M; Baba M; Tanaka T; Yasunaga C; Nishihara G; Matsuo K; Urabe M Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127 [TBL] [Abstract][Full Text] [Related]
20. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Singh AK; Avula S; Kher V; Rao DS; Mithal A Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]